Riyadh — Madeed, a preventative health and longevity platform, today announced the successful closing of a $400,000 pre-seed round, led by Vision Ventures, with participation from a group of prominent Saudi investors and entrepreneurs, including Mashhoor Aldubayan (angel investor), Mazen Darrab (Founder, Zid), and Abdullah Elyas (Co-founder, Careem).

Madeed is building the first longevity platform in the Middle East focused on true disease prevention and health optimization. Madeed uses advanced laboratory testing to identify early risk signals across hundreds of diseases before symptoms appear.

Members gain access to comprehensive blood and biomarker testing, comprehensive health reports, and clinician-reviewed notes that translate complex data into clear insights across key domains such as metabolic health, hormone balance, cardiovascular risk, and inflammation.

Beyond diagnostics, Madeed delivers actionable, personalized protocols covering lifestyle, nutrition, and supplementation designed to help individuals proactively optimize their long-term health

A core differentiator of the platform is its custom-designed daily supplement pill, formulated specifically for each member based on their blood test results, removing guesswork and fragmentation from supplementation.

Madeed was founded by Dr. Adam Bataineh, one of the leading voices in longevity and preventative medicine in the Arab world, with millions of impressions across social media platforms. Dr. Bataineh previously co-founded Span Health, a U.S.-based longevity coaching platform that was acquired by Eight Sleep.

“Healthcare in our region is still largely reactive,” said Dr. Adam Bataineh, Founder and CEO of Madeed. “We built Madeed to flip that model using data, AI, and clinical oversight to help people optimize their health, understand risk early and act decisively, long before disease takes hold.”

Kais Al Essa, Founding Partner and CEO of Vision Ventures commented: “We are excited to partner with Dr. Adam by leading this funding round to build the region’s 1st longevity platform. We saw evidence based approach through Madeed, that is backed by science with Dr. Adam and his team. We believe it is time for the region to have better awareness and services around longevity and proactive care rather than reactive.”

The pre-seed funding will be used to finalize product development, expand clinical and laboratory partnerships across the region, and launch the first cohort of members, with an initial focus on Saudi Arabia.

Madeed’s long-term vision is to become the default preventative health layer for the Middle East and beyond, combining diagnostics, intelligence, and interventions into a single, trusted longevity system.

‍About Madeed
‍Madeed is a longevity and preventative health platform focused on early disease detection and personalized interventions. By combining advanced lab testing, in-depth insights, clinician oversight, and custom supplementation, Madeed empowers individuals to take control of their long-term health years before problems arise.

‍About Vision Ventures
‍Vision Ventures is a sector-agnostic Venture Capital company that invests in early-stage technology startups in MENA. By being the only VC that is“By Entrepreneurs .. for Entrepreneurs”,VV has the needed hands-on experience to assist founders in their journey and empower them to accelerate their companies’ growth and realize their dreams. For more information, visit: http://visionvc.co/ or contact us on: info@visionvc.co